A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes

NCT02152371 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Dulaglutide
DRUG: Placebo
DRUG: Insulin Glargine
DRUG: Metformin

Sponsor

Eli Lilly and Company